Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

Correction: Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-12-01
Series:	Open Heart
Online Access:	https://openheart.bmj.com/content/8/2/e001628corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dextrans as anticoagulants and antiplatelet agents: protocol for a scoping review
by: Laurence Weinberg, et al.
Published: (2025-06-01)

Lumbar puncture in patients using anticoagulants and antiplatelet agents
by: Renan Domingues, et al.
Published: (2016-08-01)

Evaluation of Antiplatelet/Anticoagulant Use and Prognosis in Primary Thrombophilia Patients with COVID-19
by: Cenk Sunu, et al.
Published: (2024-12-01)

Antiplatelet, Anticoagulant, and Fibrinolytic Activity of Orchids: A Review
by: Berenice Fernández-Rojas, et al.
Published: (2024-12-01)

Effects of Oral Anticoagulant and Antiplatelet Agents on Performance of Multitarget Colorectal Cancer Screening Test∗
by: Reilly A. Coombs, et al.
Published: (2025-01-01)

What happens after they survive? The role of anticoagulants and antiplatelets in IVC injuries
by: Niels D Martin, et al.
Published: (2022-10-01)

Gastrointestinal Bleeding Associated with Anticoagulant and Antiplatelet Therapy
by: A. N. Severtsev, et al.
Published: (2025-01-01)

Anticoagulation and antiplatelet therapy in short bowel syndrome: A systematic review
by: Carolyn Mercer, et al.
Published: (2024-01-01)

Dental management of patients taking antiplatelet, oral anticoagulant and novel anticoagulant medications
by: Bajkin Branislav, et al.
Published: (2019-01-01)

Antiplatelets versus anticoagulants for the treatment of cervical artery dissection: Bayesian meta-analysis.
by: Hakan Sarikaya, et al.
Published: (2013-01-01)

Bleeding Risk With Combining Antiplatelets and Anticoagulants for Secondary Stroke Prevention: A Propensity Score–Matched Analysis
by: Salia Farrokh, et al.
Published: (2025-08-01)

SURGICAL TREATMENT OF HEMORRHOIDAL BLEEDING IN PATIENTS WITH CARDIOVASCULAR DISEASES UNDER ANTICOAGULANT AND ANTIPLATELET THERAPY
by: A. Z. Tsitskarava, et al.
Published: (2019-12-01)

ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?
by: D. A. Napalkov, et al.
Published: (2016-05-01)

77 Antiplatelet and Anticoagulant Bleeding Risk Reduction: A Collaborative Approach
by: Lauren Jones, et al.
Published: (2025-05-01)

The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting
by: Article Editorial
Published: (2022-01-01)

STADA and leading experts discussed the possibility of using antiplatelet agents during and after COVID-19 diseas
by: article Editorial
Published: (2022-01-01)

The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting
by: article Editorial
Published: (2022-01-01)

The antiplatelet and anticoagulant activity of 7-O-gentiobiozide formononetin in vitro and in vivo
by: Ya. F. Zverev, et al.
Published: (2016-10-01)

Comparison of outcomes between anticoagulation and antiplatelet therapies for intracranial arterial dissections
by: Seong-Joon Lee, et al.
Published: (2024-12-01)

Incidence of bleeding in patients on different anticoagulants and antiplatelet therapies undergoing thoracentesis
by: Zaid Noori, et al.
Published: (2021-01-01)

Repurposing of Antiplatelet Agent: Cilostazol for the Treatment of Alcohol-Related Liver Disease
by: Jong Ryeol Eun, et al.
Published: (2025-05-01)

187 Anticoagulation Stewardship Program Impact on Deprescribing Inappropriate Antiplatelet Therapy for Patients on Oral Anticoagulation Therapy in the Outpatient Setting
by: Josey Poppens, et al.
Published: (2025-05-01)

Efficacy and Safety of Oral Anticoagulants in the Treatment of COVID-19
by: O. G. Ni, et al.
Published: (2021-07-01)

Direct oral anticoagulant and antiplatelet therapy for extracranial neurovascular stenting in patients with atrial fibrillation
by: Xu Zheng, et al.
Published: (2025-05-01)

Current approaches to the use of antiplatelet and anticoagulant drugs in pregnant women with thrombocytopenia caused by hemostasis activation
by: O. L. Mysik, et al.
Published: (2021-05-01)

Oral anticoagulants or antiplatelet drugs after heart valve reconstructive surgery: modern guidelines for the practitioners
by: V. P. Kuzmin, et al.
Published: (2024-04-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

Effect of Treatment with Progestins and Antiplatelet Agents on IVF in Women with Adenomyosis and Recurrent Implantation Failure
by: Irina Pacu, et al.
Published: (2024-12-01)

Analysis of hemorrhagic transformation and intracerebral hemorrhage under combination therapy with alteplase and antiplatelets or anticoagulants, using the Japanese Adverse Drug Event Report database.
by: Tsuyoshi Nakai, et al.
Published: (2025-01-01)

129 Risk Mitigation of Gastrointestinal Bleeding in Patients Co-Prescribed Antiplatelets with Oral Anticoagulants: VISN 8 Anticoagulation Stewardship Proton Pump Inhibitor Initiative
by: David Parra, et al.
Published: (2025-05-01)

Navigating the Therapeutic Dilemma: Safety and Efficacy of Antiplatelet, Anticoagulation and Statin Therapy in Dengue Hemorrhagic Fever, a Case-Based Literature Review
by: N. M. M. Risly, et al.
Published: (2025-01-01)

The role of anticoagulants in the treatment of community-acquired pneumonia in patients combined with coronavirus infection
by: I. M. Fushtei, et al.
Published: (2025-02-01)

Antiplatelet Use Prior to Anticoagulant Initiation in Patients With Atrial Fibrillation-Related Ischemic Stroke: An ELAN Trial Analysis
by: Alexandros A. Polymeris, et al.
Published: (2025-05-01)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
by: Philip B. Gorelick, et al.
Published: (2013-01-01)

Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
by: Zorica M. Dimitrijevic, et al.
Published: (2024-10-01)

Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial
by: Sylvain A. Lother, et al.
Published: (2025-05-01)

Comparative-effectiveness research of COVID-19 treatment: a rapid scoping review
by: Sharon E Straus, et al.
Published: (2022-06-01)

New oral anticoagulants and their reversal agents
by: Crista L. Laslo, et al.
Published: (2018-10-01)

4th International Forum of AntiCoagulant & antiplatelet Therapy 2019 (FACTplus2019) March 21-23, 2019
by: A. Editorial
Published: (2019-03-01)

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression
by: Stanley I. Gutiontov, et al.
Published: (2020-07-01)